Adalimumab vs Risankizumab

## Adalimumab vs Risankizumab: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Risankizumab**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Risankizumab — N/A.

## Chemical Properties

**Type**: Adalimumab — Antibody; Risankizumab — Antibody.